Galen eCalcs - Calculator: SLEDAI - Galen Healthcare Solutions - Allscripts TouchWorks EHR Wiki
SLEDAI (Systemic Lupus Erythematosus Disease Activity Index) - List of Frontiers' open access articles
Real-World Effectiveness of Belimumab in Systemic Lupus Erythematosus: A Systematic Literature Review | SpringerLink
Laurent ARNAUD on Twitter: "Today, let's focus on an instrument 📒 commonly used to measure secondary outcomes in #lupus trials, the SELENA-SLEDAI #flare index (SFI) 🔥. As you can see there are
SLEDAI english
manifestations as defined by SLEDAI scoring system at time point of... | Download Scientific Diagram
PDF] SLEDAI : Systemic lupus erythematosus disease activity index SLICC : organ damage index CTC : steroids PPD : Purified Protein Derivative MDR-TB : multidrug resistant tuberculosis | Semantic Scholar
Lupus Management: Strategies for Monitoring Disease Activity and Treatment Outcomes (Transcript)
Flare, Persistently Active Disease, and Serologically Active Clinically Quiescent Disease in Systemic Lupus Erythematosus: A 2-Year Follow-Up Study | PLOS ONE
SLEDAI-2K 10 days versus SLEDAI-2K 30 days in a longitudinal evaluation | Semantic Scholar
Systemic Lupus Erythematosus Disease Activity Index (SLEDAI). | Download Table
Clinical Measures, Metrics, and Indices | Musculoskeletal Key
SLEDAI-2K descriptors and scores. | Download Scientific Diagram
xmlinkhub
Evaluation of the Lupus Low Disease Activity State (LLDAS) vs. the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI)-2K Score in a Pediatric Systemic Lupus Erythematosus Cohort - ACR Meeting Abstracts
Combined Oral Contraceptives in Women with Systemic Lupus Erythematosus | NEJM
JCM | Free Full-Text | A Comparison of the Correlation of Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) and Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS) with Health-Related Quality of Life
Selena – Sledai Assessment Tool - World OSCAR
Systemic Lupus Erythematosus Registries: Are the Measures Captured in the Real World Similar to Those in Clinical Trials? - ACR Meeting Abstracts
Table 3. | Development and Initial Validation of the Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index 50 | The Journal of Rheumatology
Who will respond to type I interferon receptor blockade in SLE? - The Lancet Rheumatology
Lupus Management: Strategies for Monitoring Disease Activity and Treatment Outcomes (Transcript)
SLEDAI | PDF | Systemic Lupus Erythematosus | Diseases And Disorders
SLEDAI english
Clinical Measures, Metrics, and Indices | Musculoskeletal Key